{"id":18,"date":"2025-01-29T11:00:55","date_gmt":"2025-01-29T11:00:55","guid":{"rendered":"https:\/\/temu.bsc.es\/multiclinsum\/?page_id=18"},"modified":"2025-10-14T10:21:00","modified_gmt":"2025-10-14T10:21:00","slug":"data","status":"publish","type":"page","link":"https:\/\/temu.bsc.es\/multiclinsum\/data\/","title":{"rendered":"Data"},"content":{"rendered":"\n<p>The available datasets are presented below<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Test Datasets<\/h2>\n\n\n\n<p>The test datasets for model evaluation are now available at <a href=\"https:\/\/zenodo.org\/records\/17341582\" data-type=\"link\" data-id=\"https:\/\/zenodo.org\/records\/15535720\">Zenodo<\/a>. Some details are described below:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>multiclinsum_test_en<\/strong>:\u00a0<strong>English test dataset<\/strong>, containing 3.396 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_test_es<\/strong>:\u00a0<strong>Spanish test dataset<\/strong>, containing 3.406 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_test_fr<\/strong>:\u00a0<strong>French test dataset<\/strong>, containing 3.469 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_test_pt<\/strong>:\u00a0<strong>Portuguese test dataset<\/strong>, containing 3.442 full-text and summary pairs.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Train Datasets<\/h2>\n\n\n\n<p>The gold standard<strong> training dataset<\/strong> is now available on <a href=\"https:\/\/zenodo.org\/records\/15517617\" data-type=\"link\" data-id=\"https:\/\/zenodo.org\/records\/15459174\">Zenodo<\/a>!<\/p>\n\n\n\n<p>The repository includes the training datasets for the multilingual clinical summarization task. Each dataset contains pairs of full-text documents and their corresponding summaries.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>multiclinsum_gs_train_en<\/strong>: Gold-standard training dataset in&nbsp;<strong>English<\/strong>, containing 592 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_gs_train_es<\/strong>: Gold-standard training dataset in&nbsp;<strong>Spanish<\/strong>, containing 592 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_gs_train_fr<\/strong>: Gold-standard training dataset in&nbsp;<strong>French<\/strong>, containing 592 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_gs_train_pt<\/strong>: Gold-standard training dataset in&nbsp;<strong>Portuguese<\/strong>, containing 592 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_large-scale_train_en<\/strong>: Large scale training dataset in <strong>English<\/strong>, containing 25.902 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_large-scale_train_es<\/strong>: Large scale training dataset in <strong>Spanish<\/strong>, containing 25.902 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_large-scale_train_fr<\/strong>: Large scale training dataset in <strong>French<\/strong>, containing 25.902 full-text and summary pairs.<\/li>\n\n\n\n<li><strong>multiclinsum_large-scale_train_pt<\/strong>: Large scale training dataset in <strong>Portuguese<\/strong>, containing 25.902 full-text and summary pairs.<\/li>\n<\/ul>\n\n\n\n<p>For each dataset, full-texts and summaries are organised in separate folders containing&nbsp;<code>.txt<\/code>&nbsp;files encoded in UTF-8. For a given language, files have nearly identical filenames, with summaries marked by the&nbsp;<code>_sum<\/code>&nbsp;suffix.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Sample Dataset<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A sample of the MultiClinSum dataset is also available on <a href=\"https:\/\/doi.org\/10.5281\/zenodo.15188951\">Zenodo<\/a>.<\/li>\n<\/ul>\n\n\n\n<p>Clinical case reports are a type of textual genre in the field of medicine that describe a patient\u2019s medical history, symptoms, diagnosis, and treatment in detail. They are usually written by healthcare providers, such as physicians, nurses, or other medical professionals, and are used to document and share information about a specific patient\u2019s condition. These reports, which are often published in peer-reviewed medical journals, are an important source of information in the field of medicine and are used to contribute to the advancement of medical knowledge and to improve patient care. They are also an important textual source for Natural Language Processing in the clinical domain, as they provide a rich source of medical information in unstructured text format that is similar to real hospital records. In some cases, these reports are published together with a summary of the text provided by the article&#8217;s authors.<\/p>\n\n\n\n<p>The MultiClinSum dataset consists of clinical case reports from various specialties extracted from open journals, paired with their human-generated summary. Together with the summarization dataset, a set of background documents will be provided. In addition, participants are allowed to use any other data source available online as long as they report it.<\/p>\n\n\n\n<p>The link to the MultiClinSum dataset, as well as a selected list of additional resources, will be posted here soon.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Samples<\/h3>\n\n\n\n<p>These are some examples of the full-text and summary document pairs in each language contained in the dataset:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">MultiClinSum-en<\/h4>\n\n\n<style>#sp-ea-98 .spcollapsing { height: 0; overflow: hidden; transition-property: height;transition-duration: 300ms;}#sp-ea-98.sp-easy-accordion>.sp-ea-single {margin-bottom: 10px; border: 1px solid #e2e2e2; }#sp-ea-98.sp-easy-accordion>.sp-ea-single>.ea-header a {color: #444;}#sp-ea-98.sp-easy-accordion>.sp-ea-single>.sp-collapse>.ea-body {background: #fff; color: #444;}#sp-ea-98.sp-easy-accordion>.sp-ea-single {background: #eee;}#sp-ea-98.sp-easy-accordion>.sp-ea-single>.ea-header a .ea-expand-icon { float: left; color: #444;font-size: 16px;}<\/style><div id=\"sp_easy_accordion-1744815491\">\n<div id=\"sp-ea-98\" class=\"sp-ea-one sp-easy-accordion\" data-ea-active=\"ea-click\" data-ea-mode=\"vertical\" data-preloader=\"\" data-scroll-active-item=\"\" data-offset-to-scroll=\"0\">\n\n<!-- Start accordion card div. -->\n<div class=\"ea-card  sp-ea-single\">\n\t<!-- Start accordion header. -->\n\t<h3 class=\"ea-header\">\n\t\t<!-- Add anchor tag for header. -->\n\t\t<a class=\"collapsed\" id=\"ea-header-980\" role=\"button\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse980\" aria-controls=\"collapse980\" href=\"#\"  aria-expanded=\"false\" tabindex=\"0\">\n\t\t<i aria-hidden=\"true\" role=\"presentation\" class=\"ea-expand-icon eap-icon-ea-expand-plus\"><\/i> Full Text\t\t<\/a> <!-- Close anchor tag for header. -->\n\t<\/h3>\t<!-- Close header tag. -->\n\t<!-- Start collapsible content div. -->\n\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse980\" data-parent=\"#sp-ea-98\" role=\"region\" aria-labelledby=\"ea-header-980\">  <!-- Content div. -->\n\t\t<div class=\"ea-body\">\n\t\t<p>A 60-year-old male patient complained of a painless mass under the nipple for more than four months. No pain, itching or nipple discharge were noted. The patient had no history of cancer and no specific family history but felt that the tumor was growing. Further immunohistochemistry investigations were recommended because a diagnosis of an invasive breast carcinoma does not exclude breast polymorphic invasive lobular carcinoma or cancer with syngenetic differentiation. The results of these investigations showed that ER, PR, HER2, E-cadherin, P120, CK5\/6, and P40 were all negative, although a high expression of Ki-67 was noted. The results obtained from the local hospital that initially treated the patient showed that these immunohistochemistry results were not specific to the liquid obtained from the biopsy, with histological analysis revealing an aggressive cancer morphology. Following intradepartmental consultation, the patient was diagnosed with a highly aggressive breast cancer consistent with a triple-negative breast lesion. The patient decided to receive a new adjuvant treatment, although his relatives complained and asked for further treatment options as there were no other obvious symptoms due to the patient\u2019s preexisting health conditions. This led to the patient seeking treatment at our hospital. An ultrasound examination carried out on admission showed that the larger gland was located below the nipple and measured 4.4 cm x 4.4 cm x 1.4 cm. Striped blood flow signals were observed in the region, with low echoes seen in the shallow fat layer measuring 1.1 cm x 0.5 cm. The integrated ultrasound diagnosis based on the mammography reports and data systems (BI-RADS) was a type 4C right breast parenchymal occupying lesion.<\/p>\n<p>Only a small number of tumor tissue biopsy samples were obtained for histology. Light microscopy showed a greater number of tumor cells and reduced stroma. The tumor cells were linear or trabecular, with some areas being monoline. The local lesions harbored a mixture of cells, with the tumor cells being large and containing fine chromatin and multiple mitotic images. The tumor cells exhibited deep staining and were disproportionate in size. Necrosis and bleeding were not observed. The results of the immunohistochemistry investigations were as follows: AE1\/AE3 (-), EMA (+), S-100 (-), CD68 (-), CD3 (weak+), CD20 (-), Pax5 (-), CD30 (+), Bcl-2 (-), CD2l (-), CD23 (-), Bcl-6 (-), MUM1 (+), CD2 (-), CD4 (+), CD8 (-), CD5 (-), CD7 (-), TIA-1 (-), GrB (+), ALK (+), CD56 (-), EBER (-), and Ki-67 (70%+). Based on the above results the pathologic diagnosis was non-Hodgkin\u2019s anaplastic large cell lymphoma in the right breast, ALK-positive.<\/p>\n<p>Interphase fluorescence in situ hybridization (FISH) analyses were then performed using the two-color fusion probes IRF4 and DUPS22, obtained from Ambipycin Pharmaceuticals Co., Ltd., Guangzhou, China. Where possible, at least 100 nuclei were evaluated for each probe. The FISH analyses were evaluated and recorded using ISIS Digital Image Analysis version 5.0 (MetaSystems, Altusheim, Australia). To analyze the whole genome for imbalance, DNA was extracted from the FFPE material using the QIAmp DNA FFPE tissue kit (Qiagen, Lab Division, America) and processed using the Oncoscan\u2122 FFPE express 3.0 kit (Affymetrix, Santa Clara, CA, USA). Processing involved analysis of copy number aberrations (CNA) and constructing copy TuScan algorithms using Nexus Express for Oncoscan 3 software (Beijing Yuxin Biotechnology Co., China). The human reference genome GRCh37\/hg19 was used for gains and deletions smaller than 100 Kb or containing less than 20 probes, and CNN-LOH for those smaller than 5000 Kb or containing deletion regions not considered in the analyses. Molecular cytogenetic analysis using interphase fluorescence in situ hybridization (FISH) analysis showed that the vast majority of cells in the tissue sections had chromosomal breakpoints that affected the fusion of the IRF4 motif and DUPS22, and chromosomal breakpoints that affected the DUPS22 motif. We also detected an additional signal for the nonrecombinant allele, suggesting a gain in the DUPS22 locus. In addition, we observed a gain in the IRF4 locus without breaks. Based on these results and with reference to the current classification of lymphoma of the World Health Organization (WHO), we changed the diagnosis to \u201cnon-Hodgkin\u2019s mesenchymal metaplastic large cell lymphoma, ALK-positive\u201d. This malignancy was not associated with an IRF4\/DUPS22 rearrangement. Chromosomal imbalance mapping using the Oncoscan\u2122 Chromosomal Imbalance Mapping platform revealed mutations in the following genes: BCOR_p.Q600X, DNMT3A_p.F609fs, NOTCH1_p.P2320fs, and IDH2_p.R140Q. Finally, we attempted to sequence the whole exome of the tumor, although unfortunately, this failed due to technical reasons.<\/p>\n\t\t<\/div> <!-- Close content div. -->\n\t<\/div> <!-- Close collapse div. -->\n<\/div> <!-- Close card div. -->\n<!-- Start accordion card div. -->\n<div class=\"ea-card  sp-ea-single\">\n\t<!-- Start accordion header. -->\n\t<h3 class=\"ea-header\">\n\t\t<!-- Add anchor tag for header. -->\n\t\t<a class=\"collapsed\" id=\"ea-header-981\" role=\"button\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse981\" aria-controls=\"collapse981\" href=\"#\"  aria-expanded=\"false\" tabindex=\"0\">\n\t\t<i aria-hidden=\"true\" role=\"presentation\" class=\"ea-expand-icon eap-icon-ea-expand-plus\"><\/i> Summary\t\t<\/a> <!-- Close anchor tag for header. -->\n\t<\/h3>\t<!-- Close header tag. -->\n\t<!-- Start collapsible content div. -->\n\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse981\" data-parent=\"#sp-ea-98\" role=\"region\" aria-labelledby=\"ea-header-981\">  <!-- Content div. -->\n\t\t<div class=\"ea-body\">\n\t\t<p>A biopsy of a breast mass in a 60-year-old Caucasian man showed a morphologic-immunophenotypic profile with features characteristic of an ALK-positive (AKT+), anaplastic large cell lymphoma. Fluorescence in situ hybridization (FISH) analysis of fixed, paraffin-embedded tissue of this lesion was performed at our institution for IRF4\/DUSP22 gene rearrangement. No rearrangement was detected. The patient presented with mutations in the following genes; BCOR_p.Q600X, DNMT3A_p.F609fs, NOTCH1_p.P2320fs, and IDH2_p.R140Q. However, the patient's consultation was complicated by the fact that he had been diagnosed with breast cancer at a local hospital and had come to our institution for further consultation. The histology findings were confirmed by immunohistochemistry and FISH. Computed tomography and positron emission tomography did not reveal nodules elsewhere in the body, which allowed the staging of the patient to be completed. However, although the patient had previously received the chemotherapy CCOP regimen (ie, cyclophosphamide, vincristine, prednisolone acetate) he did not go into remission in a timely manner and relapsed after six months, followed by a drastic deterioration in his condition after four months, resulting in his death in less than one month.<\/p>\n\t\t<\/div> <!-- Close content div. -->\n\t<\/div> <!-- Close collapse div. -->\n<\/div> <!-- Close card div. -->\n<\/div>\n<\/div>\n\n\n\n\n<h4 class=\"wp-block-heading\">MultiClinSum-es<\/h4>\n\n\n<style>#sp-ea-101 .spcollapsing { height: 0; overflow: hidden; transition-property: height;transition-duration: 300ms;}#sp-ea-101.sp-easy-accordion>.sp-ea-single {margin-bottom: 10px; border: 1px solid #e2e2e2; }#sp-ea-101.sp-easy-accordion>.sp-ea-single>.ea-header a {color: #444;}#sp-ea-101.sp-easy-accordion>.sp-ea-single>.sp-collapse>.ea-body {background: #fff; color: #444;}#sp-ea-101.sp-easy-accordion>.sp-ea-single {background: #eee;}#sp-ea-101.sp-easy-accordion>.sp-ea-single>.ea-header a .ea-expand-icon { float: left; color: #444;font-size: 16px;}<\/style><div id=\"sp_easy_accordion-1744815714\">\n<div id=\"sp-ea-101\" class=\"sp-ea-one sp-easy-accordion\" data-ea-active=\"ea-click\" data-ea-mode=\"vertical\" data-preloader=\"\" data-scroll-active-item=\"\" data-offset-to-scroll=\"0\">\n\n<!-- Start accordion card div. -->\n<div class=\"ea-card  sp-ea-single\">\n\t<!-- Start accordion header. -->\n\t<h3 class=\"ea-header\">\n\t\t<!-- Add anchor tag for header. -->\n\t\t<a class=\"collapsed\" id=\"ea-header-1010\" role=\"button\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse1010\" aria-controls=\"collapse1010\" href=\"#\"  aria-expanded=\"false\" tabindex=\"0\">\n\t\t<i aria-hidden=\"true\" role=\"presentation\" class=\"ea-expand-icon eap-icon-ea-expand-plus\"><\/i> Full Text\t\t<\/a> <!-- Close anchor tag for header. -->\n\t<\/h3>\t<!-- Close header tag. -->\n\t<!-- Start collapsible content div. -->\n\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse1010\" data-parent=\"#sp-ea-101\" role=\"region\" aria-labelledby=\"ea-header-1010\">  <!-- Content div. -->\n\t\t<div class=\"ea-body\">\n\t\t<p>Presentamos el caso del manejo de un onfalocele gigante, en un paciente con diagn\u00f3stico prenatal en semana 14. Tras el diagn\u00f3stico inicial se descartaron anomal\u00edas cromos\u00f3micas. Desde la consulta de diagn\u00f3stico prenatal del servicio de Ginecolog\u00eda y Obstetricia se contact\u00f3 con el servicio de Cirug\u00eda pedi\u00e1trica para evaluaci\u00f3n prenatal y se consider\u00f3 la infiltraci\u00f3n prenatal de toxina botul\u00ednica. En semana 37 se program\u00f3 infiltraci\u00f3n de toxina botul\u00ednica en el plano transverso del abdomen (TAP) del feto. Este proceso lo realiz\u00f3 un equipo multidisciplinar formado por ginec\u00f3logos, cirujanos pediatras, neonat\u00f3logos y anestesistas, con la gestante bajo sedaci\u00f3n. Se realiz\u00f3 sedaci\u00f3n fetal con una inyecci\u00f3n intramuscular de atropina, fentanilo y rocuronio. Dada la posici\u00f3n del feto intra\u00fatero \u00fanicamente se pudo infiltrar el plano transverso del abdomen del lado derecho del feto. Mediante una \u00fanica infiltraci\u00f3n placentaria se infiltr\u00f3 toxina botul\u00ednica (dosis 12 UI\/kg) a nivel subcostal, 10\u00aa costilla y fosa il\u00edaca derecha. Durante el proceso y en los d\u00edas siguientes no se evidenciaron complicaciones. Se program\u00f3 la ces\u00e1rea en semana 39. Al nacimiento se coloc\u00f3 silo con bolsa de pl\u00e1stico sobre el defecto y una vez el paciente estuvo relajado e intubado se infiltr\u00f3 toxina botul\u00ednica en el lado izquierdo y se realiz\u00f3 el test de relajaci\u00f3n, consiguiendo reducci\u00f3n total del contenido eviscerado e inversi\u00f3n del amnios el primer d\u00eda de vida. La presi\u00f3n intraabdominal (PIA) estuvo monitorizada en todo momento mediante sondaje vesical y mediante control del flujo renal por sistema INVOS. Se coloc\u00f3 un ap\u00f3sito hidrocoloide (Varihesive Gel ControlTM) sobre el defecto, que se cambiar\u00eda cada 48 horas. El tercer d\u00eda de vida se inici\u00f3 alimentaci\u00f3n tr\u00f3fica y el cuarto se procedi\u00f3 a la extubaci\u00f3n del paciente sin observar incidencias, pudiendo iniciar lactancia materna. El octavo d\u00eda de vida se program\u00f3 para cierre definitivo de pared y se realiz\u00f3 t\u00e9cnica de separaci\u00f3n de componentes (T\u00e9cnica de Ram\u00edrez)(7), mediante la que se incide la l\u00ednea semilunar para separar m\u00fasculo recto del m\u00fasculo obl\u00edcuo externo. Al finalizar la intervenci\u00f3n se comprob\u00f3 presi\u00f3n intraabdominal de 10 y buen flujo renal. El paciente permaneci\u00f3 intubado las primeras 24 horas postoperatorias. Inici\u00f3 tolerancia el primer d\u00eda postoperatorio, siendo la evoluci\u00f3n favorable procediendo al alta domiciliaria el 14 d\u00eda de vida.<\/p>\n\t\t<\/div> <!-- Close content div. -->\n\t<\/div> <!-- Close collapse div. -->\n<\/div> <!-- Close card div. -->\n<!-- Start accordion card div. -->\n<div class=\"ea-card  sp-ea-single\">\n\t<!-- Start accordion header. -->\n\t<h3 class=\"ea-header\">\n\t\t<!-- Add anchor tag for header. -->\n\t\t<a class=\"collapsed\" id=\"ea-header-1011\" role=\"button\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse1011\" aria-controls=\"collapse1011\" href=\"#\"  aria-expanded=\"false\" tabindex=\"0\">\n\t\t<i aria-hidden=\"true\" role=\"presentation\" class=\"ea-expand-icon eap-icon-ea-expand-plus\"><\/i> Summary\t\t<\/a> <!-- Close anchor tag for header. -->\n\t<\/h3>\t<!-- Close header tag. -->\n\t<!-- Start collapsible content div. -->\n\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse1011\" data-parent=\"#sp-ea-101\" role=\"region\" aria-labelledby=\"ea-header-1011\">  <!-- Content div. -->\n\t\t<div class=\"ea-body\">\n\t\t<p>Presentamos el caso de un hepatoonfalocele con diagn\u00f3stico prenatal, sin anomal\u00edas asociadas. En semana 37 bajo sedaci\u00f3n materna y fetal se realiz\u00f3 inyecci\u00f3n de toxina botul\u00ednica en el hemiabdomen derecho. Tras la ces\u00e1rea programada en semana 39 se complet\u00f3 inyecci\u00f3n en el hemiabdomen izquierdo y se logr\u00f3 reducci\u00f3n completa del contenido hep\u00e1tico e inversi\u00f3n total del amnios. Se realiz\u00f3 reparaci\u00f3n definitiva con separaci\u00f3n de componentes el octavo d\u00eda de vida y alta el decimocuarto d\u00eda de vida.<\/p>\n\t\t<\/div> <!-- Close content div. -->\n\t<\/div> <!-- Close collapse div. -->\n<\/div> <!-- Close card div. -->\n<\/div>\n<\/div>\n\n\n\n\n<h4 class=\"wp-block-heading\">MultiClinSum-fr<\/h4>\n\n\n<style>#sp-ea-103 .spcollapsing { height: 0; overflow: hidden; transition-property: height;transition-duration: 300ms;}#sp-ea-103.sp-easy-accordion>.sp-ea-single {margin-bottom: 10px; border: 1px solid #e2e2e2; }#sp-ea-103.sp-easy-accordion>.sp-ea-single>.ea-header a {color: #444;}#sp-ea-103.sp-easy-accordion>.sp-ea-single>.sp-collapse>.ea-body {background: #fff; color: #444;}#sp-ea-103.sp-easy-accordion>.sp-ea-single {background: #eee;}#sp-ea-103.sp-easy-accordion>.sp-ea-single>.ea-header a .ea-expand-icon { float: left; color: #444;font-size: 16px;}<\/style><div id=\"sp_easy_accordion-1744815815\">\n<div id=\"sp-ea-103\" class=\"sp-ea-one sp-easy-accordion\" data-ea-active=\"ea-click\" data-ea-mode=\"vertical\" data-preloader=\"\" data-scroll-active-item=\"\" data-offset-to-scroll=\"0\">\n\n<!-- Start accordion card div. -->\n<div class=\"ea-card  sp-ea-single\">\n\t<!-- Start accordion header. -->\n\t<h3 class=\"ea-header\">\n\t\t<!-- Add anchor tag for header. -->\n\t\t<a class=\"collapsed\" id=\"ea-header-1030\" role=\"button\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse1030\" aria-controls=\"collapse1030\" href=\"#\"  aria-expanded=\"false\" tabindex=\"0\">\n\t\t<i aria-hidden=\"true\" role=\"presentation\" class=\"ea-expand-icon eap-icon-ea-expand-plus\"><\/i> Full Text\t\t<\/a> <!-- Close anchor tag for header. -->\n\t<\/h3>\t<!-- Close header tag. -->\n\t<!-- Start collapsible content div. -->\n\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse1030\" data-parent=\"#sp-ea-103\" role=\"region\" aria-labelledby=\"ea-header-1030\">  <!-- Content div. -->\n\t\t<div class=\"ea-body\">\n\t\t<p>Patiente de 32 ans, cultivatrice, en provenance de la Guin\u00e9e, admise dans le service le 8 juin 2022 pour fi\u00e8vre et conscience alt\u00e9r\u00e9e. Sa symptomatologie serait d'installation progressive depuis dix jours environ, pr\u00e9c\u00e9d\u00e9e d'une fi\u00e8vre permanente, de c\u00e9phal\u00e9es et de vomissements. Elle est apparue apr\u00e8s une r\u00e9vision ut\u00e9rine dans une structure sanitaire guin\u00e9enne le 25 mai 2022 pour avortement spontan\u00e9 d'une grossesse de 18 semaines d'am\u00e9norrh\u00e9e. Elle \u00e9tait trait\u00e9e avant son admission pour m\u00e9ningite bact\u00e9rienne et infection g\u00e9nitale suspecte par ceftriaxone et m\u00e9tronidazole injectables. Elle n'avait aucun ant\u00e9c\u00e9dent m\u00e9dico-chirurgical connu, ni de notion d'usage d'immunosuppresseurs. L'examen physique de la patiente a objectiv\u00e9 un indice de masse corporelle (IMC) \u00e0 20,9 kg\/m2 pour un poids de 61 kg, une fi\u00e8vre \u00e0 39,2\u00b0C, un score SOFA (Sequential Organ Failure Assessment) \u00e0 3 (1 pour la pression art\u00e9rielle moyenne \u00e0 65 mmHg et 2 pour le score de Glasgow \u00e0 11\/15), des convulsions tonicocloniques g\u00e9n\u00e9ralis\u00e9es, une raideur m\u00e9ning\u00e9e, une h\u00e9mipl\u00e9gie droite. Il existait une infection g\u00e9nitale : lochies purulentes, ut\u00e9rus pelvien non retract\u00e9.<\/p>\n<p>La tomodensitom\u00e9trie cr\u00e2nio-c\u00e9r\u00e9brale a mis en \u00e9vidence une large plage d'hypodensit\u00e9 h\u00e9misph\u00e9rique gauche, rehauss\u00e9e par le produit de contraste avec important effet de masse. Au bilan biologique, on constatait une hypoglyc\u00e9mie capillaire \u00e0 3,2 mmol\/l, une clairance de la cr\u00e9atinine (selon la formule CKDEPI) \u00e0 155,32 ml\/mn pour une cr\u00e9atinin\u00e9mie \u00e0 38,5 \u00b5mol\/l, des transaminases ALAT \u00e0 58 Ul\/l, et un groupe sanguin O positif. L'examen du liquide c\u00e9r\u00e9bro-spinal (LCS) montrait un liquide purulent, une hyperleucocytorachie \u00e0 1 100\/mm3 \u00e0 pr\u00e9dominance neutrophile, une hypoglycorachie \u00e0 1,2 mmol\/l, une hyperprot\u00e9inorachie \u00e0 1,8 g\/l, des bacilles gram n\u00e9gatif E. coli r\u00e9sistants aux p\u00e9nicillines (amoxicilline, ampicilline, amoxiacide clavulanique), aux carboxyp\u00e9nicillines (ticarcilline), aux c\u00e9phalosporines (ceftriaxone, cefixime, cefalotine, cefepime), aux quinolones (ciprofloxacine, norfloxacine), aux cyclines (t\u00e9tracycline) et au cotrimoxazole.<\/p>\n<p>L'h\u00e9moculture sur milieu a\u00e9robie et l'examen du pr\u00e9l\u00e8vement vaginal ont isol\u00e9 la m\u00eame souche. L'h\u00e9mogramme a mis en \u00e9vidence une an\u00e9mie s\u00e9v\u00e8re (\u00e0 4,2 g\/dl d'h\u00e9moglobine), normocytaire (VGM \u00e0 85,2 fl), normochrome (CCMH \u00e0 32,7 g\/dl), r\u00e9g\u00e9n\u00e9rative (r\u00e9ticulocytes \u00e0 160 g\/l), des leucocytes \u00e0 8 000\/mm3 (neutrophiles \u00e0 6 200\/mm3, lymphocytes \u00e0 1 000\/mm3) et des plaquettes \u00e0 14 000\/\u00b5l. Deux s\u00e9rologies VIH se sont r\u00e9v\u00e9l\u00e9es n\u00e9gatives, et le taux de CD4 \u00e9tait \u00e0 850 cellules\/mm3 de sang. Le diagnostic de sepsis post abortum, compliqu\u00e9 de m\u00e9ningoenc\u00e9phalite \u00e0 E. coli multir\u00e9sistant et d'an\u00e9mie s\u00e9v\u00e8re a alors \u00e9t\u00e9 retenu.<\/p>\n<p>D\u00e8s l'admission, elle avait \u00e9t\u00e9 mise sous amoxiacide-clavulanique en raison de 2 g toutes les huit heures et amikacine 1 g\/jour en intraveineuse. Au 4e jour, \u00e0 la suite des r\u00e9sultats de l'antibiogramme, le traitement par m\u00e9ropenem a \u00e9t\u00e9 instaur\u00e9 \u00e0 raison de 2 g toutes les huit heures en intraveineuse pendant 21 jours. L'an\u00e9mie s\u00e9v\u00e8re a \u00e9t\u00e9 corrig\u00e9e par la transfusion journali\u00e8re de 450 ml de concentr\u00e9 \u00e9rythrocytaire isogroupe-isorh\u00e9sus pendant six jours. L'hypoglyc\u00e9mie a \u00e9t\u00e9 corrig\u00e9e par une perfusion de 500 ml de s\u00e9rum glucos\u00e9 10 %, les convulsions par l'administration de diaz\u00e9pam. Par ailleurs, des toilettes g\u00e9nitales biquotidiennes \u00e0 la chlorhexidine pendant cinq jours et de la kin\u00e9sith\u00e9rapie au 8e jour du traitement par m\u00e9ropenem ont \u00e9t\u00e9 r\u00e9alis\u00e9es. L\u2019\u00e9volution a \u00e9t\u00e9 favorable, marqu\u00e9e par l'apyrexie au 4e jour de la bi-antibioth\u00e9rapie, l'amendement des convulsions, et la reprise de la conscience respectivement au 2e et au 7e jour du traitement par m\u00e9ropenem. L'h\u00e9moglobine de contr\u00f4le est revenue \u00e0 11,9 g\/ dl au 7e jour de la transfusion sanguine. La force motrice des membres droits d\u00e9ficitaires a \u00e9t\u00e9 mesur\u00e9e \u00e0 1\/5 et 3\/5 respectivement au 7e et au 4e jour de la kin\u00e9sith\u00e9rapie. L'ex\u00e9at a \u00e9t\u00e9 autoris\u00e9 le 5 juillet 2022, avec kin\u00e9sith\u00e9rapie en ambulatoire et un rendez-vous quatorze jours apr\u00e8s. \u00c0 ce rendez-vous, l\u2019\u00e9volution \u00e9tait globalement favorable avec une force motrice des membres initialement d\u00e9ficitaires \u00e0 5\/5.<\/p>\n\t\t<\/div> <!-- Close content div. -->\n\t<\/div> <!-- Close collapse div. -->\n<\/div> <!-- Close card div. -->\n<!-- Start accordion card div. -->\n<div class=\"ea-card  sp-ea-single\">\n\t<!-- Start accordion header. -->\n\t<h3 class=\"ea-header\">\n\t\t<!-- Add anchor tag for header. -->\n\t\t<a class=\"collapsed\" id=\"ea-header-1031\" role=\"button\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse1031\" aria-controls=\"collapse1031\" href=\"#\"  aria-expanded=\"false\" tabindex=\"0\">\n\t\t<i aria-hidden=\"true\" role=\"presentation\" class=\"ea-expand-icon eap-icon-ea-expand-plus\"><\/i> Summary\t\t<\/a> <!-- Close anchor tag for header. -->\n\t<\/h3>\t<!-- Close header tag. -->\n\t<!-- Start collapsible content div. -->\n\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse1031\" data-parent=\"#sp-ea-103\" role=\"region\" aria-labelledby=\"ea-header-1031\">  <!-- Content div. -->\n\t\t<div class=\"ea-body\">\n\t\t<p>La premi\u00e8re, qui avait avort\u00e9 r\u00e9cemment, \u00e9tait sous traitement par ceftriaxone quand elle a \u00e9t\u00e9 admise pour syndrome m\u00e9ning\u00e9 et syndrome pyramidal li\u00e9 \u00e0 une l\u00e9sion c\u00e9r\u00e9brale. Du liquide c\u00e9phalorachidien (LCR), du sang et d'un pr\u00e9l\u00e8vement de s\u00e9cr\u00e9tions g\u00e9nitales purulentes a \u00e9t\u00e9 isol\u00e9 E. coli r\u00e9sistant aux p\u00e9nicillines et c\u00e9phalosporines. Elle a gu\u00e9ri sous traitement par m\u00e9rop\u00e9nem pendant 21 jours, avec peu de s\u00e9quelles.<\/p>\n\t\t<\/div> <!-- Close content div. -->\n\t<\/div> <!-- Close collapse div. -->\n<\/div> <!-- Close card div. -->\n<\/div>\n<\/div>\n\n\n\n\n<h4 class=\"wp-block-heading\">MultiClinSum-pt<\/h4>\n\n\n<style>#sp-ea-105 .spcollapsing { height: 0; overflow: hidden; transition-property: height;transition-duration: 300ms;}#sp-ea-105.sp-easy-accordion>.sp-ea-single {margin-bottom: 10px; border: 1px solid #e2e2e2; }#sp-ea-105.sp-easy-accordion>.sp-ea-single>.ea-header a {color: #444;}#sp-ea-105.sp-easy-accordion>.sp-ea-single>.sp-collapse>.ea-body {background: #fff; color: #444;}#sp-ea-105.sp-easy-accordion>.sp-ea-single {background: #eee;}#sp-ea-105.sp-easy-accordion>.sp-ea-single>.ea-header a .ea-expand-icon { float: left; color: #444;font-size: 16px;}<\/style><div id=\"sp_easy_accordion-1744815913\">\n<div id=\"sp-ea-105\" class=\"sp-ea-one sp-easy-accordion\" data-ea-active=\"ea-click\" data-ea-mode=\"vertical\" data-preloader=\"\" data-scroll-active-item=\"\" data-offset-to-scroll=\"0\">\n\n<!-- Start accordion card div. -->\n<div class=\"ea-card  sp-ea-single\">\n\t<!-- Start accordion header. -->\n\t<h3 class=\"ea-header\">\n\t\t<!-- Add anchor tag for header. -->\n\t\t<a class=\"collapsed\" id=\"ea-header-1050\" role=\"button\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse1050\" aria-controls=\"collapse1050\" href=\"#\"  aria-expanded=\"false\" tabindex=\"0\">\n\t\t<i aria-hidden=\"true\" role=\"presentation\" class=\"ea-expand-icon eap-icon-ea-expand-plus\"><\/i> Full Text\t\t<\/a> <!-- Close anchor tag for header. -->\n\t<\/h3>\t<!-- Close header tag. -->\n\t<!-- Start collapsible content div. -->\n\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse1050\" data-parent=\"#sp-ea-105\" role=\"region\" aria-labelledby=\"ea-header-1050\">  <!-- Content div. -->\n\t\t<div class=\"ea-body\">\n\t\t<p>Mulher de 38 anos com hist\u00f3ria de neurite \u00f3ptica do lado esquerdo diagnosticada aos 30 anos, com s\u00edndrome clinicamente isolada, obteve recupera\u00e7\u00e3o completa da defici\u00eancia visual com tratamento com esteroides. Desde ent\u00e3o, tomava regularmente c\u00e1psulas de B. serrata (200mg\/dia, dose recomendada pelo fabricante) para fortalecer seu sistema imunol\u00f3gico. Ela desenvolveu hipersensibilidade \u00e0 luz, dor ocular, n\u00e1usea, tontura e fraqueza nos membros inferiores 4 dias ap\u00f3s tomar a primeira dose da vacina BNT162b2 em julho de 2021 e aumentou a dose de B. serrata para cinco c\u00e1psulas (1.000mg\/dia) 1 semana ap\u00f3s a vacina\u00e7\u00e3o. Ap\u00f3s tomar B. serrata na dose de 1.000mg\/dia por 3 semanas, a paciente sofreu uma convuls\u00e3o t\u00f4nico-cl\u00f4nica generalizada n\u00e3o provocada e foi internada na unidade de terapia intensiva. A investiga\u00e7\u00e3o revelou hiponatremia s\u00e9rica (112mmol\/L [n, 135 - 150mmol\/L]), concentra\u00e7\u00e3o de s\u00f3dio urin\u00e1rio de 58mmol\/L, osmolaridade s\u00e9rica de 234mosm\/kg (n, 280 - 300mosm\/kg), osmolaridade urin\u00e1ria de 739mosm\/kg (n, 450 - 600mosm\/kg), concentra\u00e7\u00e3o de ACTH de 85,9pg\/mL (n, 7,2 - 63,3pg\/mL), concentra\u00e7\u00e3o normal de cortisol basal, concentra\u00e7\u00e3o normal de prote\u00edna C-reativa, contagem de leuc\u00f3citos de 11,4 (n, &lt; 10\/l), neutrofilia, linfopenia e rabdomi\u00f3lise (concentra\u00e7\u00e3o m\u00e1xima de creatina quinase de 76348U\/L (n, 1 - 145U\/L). Realizou resson\u00e2ncia magn\u00e9tica do cr\u00e2nio (RMC), que revelou tr\u00eas les\u00f5es periventriculares, n\u00e3o real\u00e7adas, que n\u00e3o mudaram em n\u00famero e nem em extens\u00e3o em compara\u00e7\u00e3o com a RMC feita 4 anos antes. A gl\u00e2ndula pituit\u00e1ria estava normal. A investiga\u00e7\u00e3o de malignidade foi pouco esclarecedora. A paciente foi diagnosticada com SIHAD e tratada com levetiracetam, diurese for\u00e7ada e infus\u00f5es de cloreto de s\u00f3dio. Ap\u00f3s 3 semanas de tratamento e interrup\u00e7\u00e3o do uso de c\u00e1psulas de B. serrata, a paciente se recuperou completamente.<\/p>\n\t\t<\/div> <!-- Close content div. -->\n\t<\/div> <!-- Close collapse div. -->\n<\/div> <!-- Close card div. -->\n<!-- Start accordion card div. -->\n<div class=\"ea-card  sp-ea-single\">\n\t<!-- Start accordion header. -->\n\t<h3 class=\"ea-header\">\n\t\t<!-- Add anchor tag for header. -->\n\t\t<a class=\"collapsed\" id=\"ea-header-1051\" role=\"button\" data-sptoggle=\"spcollapse\" data-sptarget=\"#collapse1051\" aria-controls=\"collapse1051\" href=\"#\"  aria-expanded=\"false\" tabindex=\"0\">\n\t\t<i aria-hidden=\"true\" role=\"presentation\" class=\"ea-expand-icon eap-icon-ea-expand-plus\"><\/i> Summary\t\t<\/a> <!-- Close anchor tag for header. -->\n\t<\/h3>\t<!-- Close header tag. -->\n\t<!-- Start collapsible content div. -->\n\t<div class=\"sp-collapse spcollapse spcollapse\" id=\"collapse1051\" data-parent=\"#sp-ea-105\" role=\"region\" aria-labelledby=\"ea-header-1051\">  <!-- Content div. -->\n\t\t<div class=\"ea-body\">\n\t\t<p>Uma mulher de 38 anos diagnosticada com s\u00edndrome clinicamente isolada tomava regularmente c\u00e1psulas de B. serrata (200mg\/dia) para fortalecer seu sistema imunol\u00f3gico. Ela desenvolveu hipersensibilidade \u00e0 luz, dor ocular, n\u00e1usea, tontura e fraqueza nos membros inferiores 4 dias ap\u00f3s tomar a primeira dose da vacina BNT162b2 e aumentou a dose de B. serrata para 1.000mg\/dia 1 semana ap\u00f3s a vacina\u00e7\u00e3o. Ap\u00f3s tomar B. serrata na dose de 1.000mg\/dia por 3 semanas, ela foi internada na unidade de terapia intensiva devido \u00e0 convuls\u00e3o t\u00f4nico-cl\u00f4nica generalizada n\u00e3o provocada. A investiga\u00e7\u00e3o diagn\u00f3stica revelou s\u00edndrome da secre\u00e7\u00e3o inapropriada de horm\u00f4nio antidiur\u00e9tico, que se resolveu completamente ap\u00f3s tratamento e interrup\u00e7\u00e3o do uso de B. serrata.<\/p>\n\t\t<\/div> <!-- Close content div. -->\n\t<\/div> <!-- Close collapse div. -->\n<\/div> <!-- Close card div. -->\n<\/div>\n<\/div>\n\n\n\n\n<h2 class=\"wp-block-heading\">Other resources and datasets<\/h2>\n\n\n\n<p><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Text summarization datasets released at <a href=\"https:\/\/paperswithcode.com\/datasets?task=text-summarization&amp;page=1\">paperswithcode<\/a><\/li>\n\n\n\n<li>DUC workshop and <a href=\"https:\/\/www-nlpir.nist.gov\/projects\/duc\/data.html\">datasets<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/github.com\/abachaa\/MEDIQA2021\">MEDIQA2021<\/a> shared task and data<\/li>\n\n\n\n<li><a href=\"https:\/\/github.com\/allenai\/mslr-shared-task\">MSLR2022<\/a> shared Task and data<\/li>\n\n\n\n<li><a href=\"https:\/\/stanford-aimi.github.io\/RRG24\/\">RRG24<\/a> shared task and data<\/li>\n\n\n\n<li><a href=\"https:\/\/stanford-aimi.github.io\/discharge-me\/\">Discharge me!<\/a> shared task and dataset<\/li>\n\n\n\n<li><a href=\"https:\/\/peranssumm.github.io\/\">PerAnsSum<\/a> shared task and dataset<\/li>\n\n\n\n<li><a href=\"https:\/\/physionet.org\/content\/bionlp-workshop-2023-task-1a\/2.0.0\/\">ProbSum<\/a> shared task and data<\/li>\n\n\n\n<li><a href=\"https:\/\/github.com\/WING-NUS\/scisumm-corpus\">CL-SciSumm<\/a> Shared Task corpus<\/li>\n\n\n\n<li><a href=\"https:\/\/github.com\/StanfordMIMI\/clin-summ\">Clin-summ<\/a> implementation <\/li>\n\n\n\n<li><a href=\"https:\/\/github.com\/ckbjimmy\/clneg\">Clinical Text Summarization Tool<\/a> with Syntax-based Negation and Semantic Concept Identification<\/li>\n\n\n\n<li><a href=\"https:\/\/github.com\/Avent-IQ\/text-summarization-for-clinical-trial-results\">Text summarization<\/a> for Clinical Trial Results<\/li>\n\n\n\n<li><a href=\"https:\/\/github.com\/tiru-patel\/Medical_Text_Summarization_using_LLMs\">Medical text<\/a> summarization<\/li>\n\n\n\n<li><a href=\"https:\/\/github.com\/LuJunru\/NapSS\">NapSS<\/a>: Paragraph-level Medical Text Simplification via Narrative Prompting and Sentence-matching Summarization<\/li>\n\n\n\n<li><a href=\"https:\/\/github.com\/databricks-industry-solutions\/jsl-medical-text-summarization\">Medical Text Summarization<\/a> with John Snow Labs<\/li>\n<\/ol>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The available datasets are presented below Test Datasets The test datasets for model evaluation are now available at Zenodo. Some details are described below: Train Datasets The gold standard training dataset is now available on Zenodo! The repository includes the training datasets for the multilingual clinical summarization task. Each dataset contains pairs of full-text documents [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-18","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/temu.bsc.es\/multiclinsum\/wp-json\/wp\/v2\/pages\/18","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temu.bsc.es\/multiclinsum\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/temu.bsc.es\/multiclinsum\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/temu.bsc.es\/multiclinsum\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/temu.bsc.es\/multiclinsum\/wp-json\/wp\/v2\/comments?post=18"}],"version-history":[{"count":25,"href":"https:\/\/temu.bsc.es\/multiclinsum\/wp-json\/wp\/v2\/pages\/18\/revisions"}],"predecessor-version":[{"id":298,"href":"https:\/\/temu.bsc.es\/multiclinsum\/wp-json\/wp\/v2\/pages\/18\/revisions\/298"}],"wp:attachment":[{"href":"https:\/\/temu.bsc.es\/multiclinsum\/wp-json\/wp\/v2\/media?parent=18"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}